Mega Genomics Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Mega Genomics.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Healthcare earnings growth18.3%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Shareholders Will Be Pleased With The Quality of Mega Genomics' (HKG:6667) Earnings

Oct 03
Shareholders Will Be Pleased With The Quality of Mega Genomics' (HKG:6667) Earnings

Returns On Capital Signal Tricky Times Ahead For Mega Genomics (HKG:6667)

Aug 28
Returns On Capital Signal Tricky Times Ahead For Mega Genomics (HKG:6667)

Some Investors May Be Worried About Mega Genomics' (HKG:6667) Returns On Capital

May 03
Some Investors May Be Worried About Mega Genomics' (HKG:6667) Returns On Capital

Calculating The Intrinsic Value Of Mega Genomics Limited (HKG:6667)

Feb 20
Calculating The Intrinsic Value Of Mega Genomics Limited (HKG:6667)

Mega Genomics Limited's (HKG:6667) Share Price Could Signal Some Risk

Aug 12
Mega Genomics Limited's (HKG:6667) Share Price Could Signal Some Risk

A Look At The Fair Value Of Mega Genomics Limited (HKG:6667)

Nov 07
A Look At The Fair Value Of Mega Genomics Limited (HKG:6667)

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Mega Genomics has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

SEHK:6667 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/20241603287111N/A
3/31/202415631107138N/A
12/31/202315130128164N/A
9/30/20231491599126N/A
6/30/202314707188N/A
3/31/2023146-92940N/A
12/31/2022146-18-12-7N/A
9/30/202219222-32N/A
6/30/202223862610N/A
3/31/2022238701621N/A
12/31/2021237792631N/A
12/31/202020379102103N/A
12/31/2019124303737N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 6667's forecast earnings growth is above the savings rate (2.3%).

Earnings vs Market: Insufficient data to determine if 6667's earnings are forecast to grow faster than the Hong Kong market

High Growth Earnings: Insufficient data to determine if 6667's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 6667's revenue is forecast to grow faster than the Hong Kong market.

High Growth Revenue: Insufficient data to determine if 6667's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if 6667's Return on Equity is forecast to be high in 3 years time


Discover growth companies